This is a commonly made claim by influencers about microdosing, but its a marketing ploy thats not supported by evidence
These statements have not been evaluated by the FDA
Clinical discussions of this issue generally focus on indirect pathways rather than direct endocrine effects
Pratt also worries more about the long-term effects in children We have no idea what the long-term outcomes are going to be, she said
Common GLP-1 medications include: Semaglutide (Ozempic, Wegovy, Rybelsus) Liraglutide (Saxenda, Victoza) Tirzepatide (Mounjaro, Zepbound) These medications help with weight loss by: Reducing appetite and food cravings Making you feel full sooner during meals Slowing digestion so you stay satisfied longer Helping regulate blood sugar levels Most people receive these medications as weekly injections, though some come as daily pills
Because it is not peptide-based, it can survive digestion and be absorbed through the gastrointestinal tract
